DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Francis PA, Regan MM, Fleming GF et al.
Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): analysis of the SOFT trial. San Antonio Breast Cancer Symposium 2014; S3-08.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.